2Van Rie A, Page - Shipp L, Scott L, et aL Xpert@ MTB/RIF for point - of - care diagnosis of TB in high - HIV burden, resource - limited countries: hype or hope? [J]. Expert Rev Mol Diagn, 2010, 10(7): 937-946.
4Helb D, Jones M, Story E, et al. Rapid Detection of Mycobaeerium tuberculosis andrifampin resistance by use of on - demand, near - patient technology[ J]. J Clin Mierebiol, 2010, 48 ( 1 ) : 229 - 237.
5Malbruny B, Le Manic G, Courageux K, Ct al. Rapid and efficient detection of Mycobacterium tuberculosis in respiratory and non - re- spiratory samples[J]. Int J Tuberc Lung Dis, 2011, 15(4) : 553 - 555.
6Boehme CC, Nabeta P, Hillemann D, et al. Rapid moleeulardetee- tion of tuberculosis and rifampin resistance [ J ]. N Engl J Ned, 2010, 363(11) : 1005 -1015.
7World Health Organization. Global tuberculosis control. WHO/HTM/TB/201116 2011. Geneva: World Health Or- ganization, 2011.
8World Health Organization. Anti Tuberculosis drug resistance in the world., the WHO/IUATLD global project on anti tuber- culosis drug resistance surveillance, 1994-1997. Geneva: World Health Organization, 1997: 154-227.
9World Health Organization. Towards universal access to diag nosis and treatment of multi drug-resistant and extensively drug resistant tuberculosis by 2015. WHO/HTM/TB/ 2011.3.
10Geneva: World Health Organization,2011. Perez-Velez CM. Pediatric tuberculosis: new guidelines and recommendations. Curr Opin Pediatr, 2012, 24(3) :319- 328.
